MARK ODANIEL: Open Payments
NPI 1164529640 · ROCKY MOUNT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 31 payments from 7 companies in 2025. Trend: 2023 $13,536 · 2024 $2,632 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $218 |
| E.R. Squibb & Sons, L.L.C. | 10 | $150 |
| Alkermes, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Luye Pharma (USA) Ltd. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: INVEGA SUSTENNA, COBENFY, ARISTADA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, INGREZZA, SPRAVATO, ABILIFY MAINTENA.
Industry payments across NC — which companies pay providers there.
